BioLargo, Inc.

BioLargo, Inc.

BLGO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$23.43M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioLargo, Inc.BioLargo, Inc.-1.5-202%--1.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$23.43 Million
Enterprise Value$30.32 Million
Earnings per Share$-0.04
Beta-0.13
Outstanding Shares320,983,589

Return

Return on Equity201.63%ROE
Return on Assets-147.05%
Return on Invested Capital-1197.34%

Valuation & Multiples

P/E Ratio-1.55P/E Ratio
PEG2.59PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.07Price to Book Ratio
Enterprise Value to Revenue7.45
Enterprise Value to EBIT-1.98
Enterprise Value to Net Income-3
Total Debt to Enterprise0.28
Debt to Equity-1.6Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 18, 2026
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
$1.37 M
Consensus analyst estimate

Next Earnings Call

Expected Date
April 5, 2027
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
$1.26 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.04%0%
Total Invested$9,604▼ 28.19%
Investors Holding10%

About BioLargo, Inc.

45 employees
CEO: Dennis Calvert

BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) ...

Questions & Answers